Were there any open-market share purchases or sales in this Kamada (KMDA) Form 4?

No, the Form 4 shows no open-market purchases or sales. All transactions are employee stock option grants and related dispositions to the issuer, recorded as derivative awards held by a trustee under Kamada’s 2011 Share Award Plan for ordinary shares.

Kamada CEO reports option grant adjustments

Kamada Ltd Chief Executive Officer Amir London reported a series of compensation-related option changes, not open-market trading.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Kamada Ltd Chief Executive Officer Amir London reported a series of compensation-related option changes, not open-market trading. A trustee under Kamada’s 2011 Share Award Plan received several grants of employee stock options for 100,000 ordinary shares each at exercise prices such as $5.87 and $7.25, while matching 100,000-option awards at $6.12 and $7.50 were returned to the company.

According to the notes, the exercise prices were adjusted under the 2011 Share Award Plan after a cash dividend declared on March 11, 2026, with no other changes to the award terms. The options vest in four equal annual installments and are held by a trustee under the plan.

Insider Trade Summary

16 transactions reported

Mixed 16 txns

Insider London Amir

Role Chief Executive Officer

Type	Security	Shares	Price	Value
Grant/Award	Employee Stock Option (right to buy)	100,000	$0.00	$0.00
Disposition	Employee Stock Option (right to buy)	100,000	$0.00	$0.00
Grant/Award	Employee Stock Option (right to buy)	100,000	$0.00	$0.00
Disposition	Employee Stock Option (right to buy)	100,000	$0.00	$0.00
Grant/Award	Employee Stock Option (right to buy)	100,000	$0.00	$0.00
Disposition	Employee Stock Option (right to buy)	100,000	$0.00	$0.00
Grant/Award	Employee Stock Option (right to buy)	100,000	$0.00	$0.00
Disposition	Employee Stock Option (right to buy)	100,000	$0.00	$0.00
Grant/Award	Employee Stock Option (right to buy)	100,000	$0.00	$0.00
Disposition	Employee Stock Option (right to buy)	100,000	$0.00	$0.00
Grant/Award	Employee Stock Option (right to buy)	100,000	$0.00	$0.00
Disposition	Employee Stock Option (right to buy)	100,000	$0.00	$0.00
Grant/Award	Employee Stock Option (right to buy)	100,000	$0.00	$0.00
Disposition	Employee Stock Option (right to buy)	100,000	$0.00	$0.00
Grant/Award	Employee Stock Option (right to buy)	100,000	$0.00	$0.00
Disposition	Employee Stock Option (right to buy)	100,000	$0.00	$0.00

Holdings After Transaction: Employee Stock Option (right to buy) — 1,600,000 contracts (Indirect, Held by trustee)

Footnotes (4)

F1. All exercise prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of April 6, 2026.
F2. The exercise price of the options was adjusted pursuant to the provisions of the Company's 2011 Share Award Plan in connection with a cash dividend distribution declared by the Company's board of directors on March 11, 2026. There are no other changes to the terms and conditions of the option award.
F3. Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant.
F4. Held by trustee under the Company's 2011 Share Award Plan.

Key Figures

Option grant size: 100,000 options Exercise price (series 1): $5.87 per share Exercise price (series 2): $6.12 per share +4 more

7 metrics

Option grant size 100,000 options Each employee stock option award for ordinary shares

Exercise price (series 1) $5.87 per share Employee stock options after adjustment, various grant dates

Exercise price (series 2) $6.12 per share Employee stock options returned to issuer

Exercise price (series 3) $7.25 per share Employee stock options after adjustment, later expirations

Exercise price (series 4) $7.50 per share Employee stock options returned to issuer

Expiration date (first group) June 22, 2029 Options linked to 2023–2026 exercise dates

Expiration date (later group) December 10, 2035 Options linked to 2026–2029 exercise dates

Key Terms

Employee Stock Option (right to buy), Disposition to issuer, 2011 Share Award Plan, exercise price, +2 more

6 terms

Employee Stock Option (right to buy) financial

"security_title: "Employee Stock Option (right to buy)""

Disposition to issuer financial

"transaction_code_description: "Disposition to issuer""

exercise price financial

"The exercise price of the options was adjusted pursuant to the provisions of the Company's 2011 Share Award Plan"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

cash dividend distribution financial

"in connection with a cash dividend distribution declared by the Company's board of directors on March 11, 2026."

vesting financial

"Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant."

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Kamada (KMDA) report for CEO Amir London?

Kamada reported that a trustee for CEO Amir London received several grants of 100,000 employee stock options while returning matching 100,000-option awards to the company. These transactions involved option grant acquisitions and dispositions to the issuer, not open-market share purchases or sales.

What are the key option exercise prices in Kamada (KMDA) CEO’s Form 4 filing?

The filing lists employee stock options with exercise prices of $5.87, $6.12, $7.25, and $7.50 per ordinary share. Footnotes explain these U.S. dollar amounts reflect conversions from NIS using a Bank of Israel exchange rate as of April 6, 2026.

Why were Kamada (KMDA) CEO option exercise prices adjusted in this filing?

Footnotes state the option exercise prices were adjusted under Kamada’s 2011 Share Award Plan following a cash dividend distribution declared by the board on March 11, 2026. The company notes there are no other changes to the terms and conditions of the option award.

How do the Kamada (KMDA) CEO options reported here vest over time?

The options reported vest in four equal annual installments, with 25% vesting on each of the four anniversaries of the grant date. This creates a long-term incentive structure aligning the timing of CEO equity benefits with multi-year service at Kamada.

Who legally holds the Kamada (KMDA) CEO options shown in the Form 4?

The Form 4 indicates the options are held indirectly, by a trustee under Kamada’s 2011 Share Award Plan. The nature of ownership is coded as indirect and described in the footnotes as “Held by trustee under the Company’s 2011 Share Award Plan.”

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 04/09/2026 - 03:17 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

London Amir

(Last)

(First)

(Middle)

2 HOLTZMAN ST.

(Street)

REHOVOT

(City)

(State)

(Zip)

ISRAEL

(Country)

2. Issuer Name and Ticker or Trading Symbol
KAMADA LTD [ KMDA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Executive Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/07/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Employee Stock Option (right to buy)	$5.87⁽¹⁾⁽²⁾	04/07/2026		A		100,000		12/22/2023⁽³⁾	06/22/2029	Ordinary Shares	100,000	⁽²⁾	100,000	I	Held by trustee⁽⁴⁾
Employee Stock Option (right to buy)	$6.12⁽¹⁾	04/07/2026		D			100,000	12/22/2023⁽³⁾	06/22/2029	Ordinary Shares	100,000	⁽²⁾	100,000	I	Held by trustee⁽⁴⁾
Employee Stock Option (right to buy)	$5.87⁽¹⁾⁽²⁾	04/07/2026		A		100,000		12/22/2024⁽³⁾	06/22/2029	Ordinary Shares	100,000	⁽²⁾	100,000	I	Held by trustee⁽⁴⁾
Employee Stock Option (right to buy)	$6.12⁽¹⁾	04/07/2026		D			100,000	12/22/2024⁽³⁾	06/22/2029	Ordinary Shares	100,000	⁽²⁾	100,000	I	Held by trustee⁽⁴⁾
Employee Stock Option (right to buy)	$5.87⁽¹⁾⁽²⁾	04/07/2026		A		100,000		12/22/2025⁽³⁾	06/22/2029	Ordinary Shares	100,000	⁽²⁾	100,000	I	Held by trustee⁽⁴⁾
Employee Stock Option (right to buy)	$6.12⁽¹⁾	04/07/2026		D			100,000	12/22/2025⁽³⁾	06/22/2029	Ordinary Shares	100,000	⁽²⁾	100,000	I	Held by trustee⁽⁴⁾
Employee Stock Option (right to buy)	$7.25⁽¹⁾⁽²⁾	04/07/2026		A		100,000		12/10/2026⁽³⁾	12/10/2035	Ordinary Shares	100,000	⁽²⁾	100,000	I	Held by trustee⁽⁴⁾
Employee Stock Option (right to buy)	$7.5⁽¹⁾	04/07/2026		D			100,000	12/10/2026⁽³⁾	12/10/2035	Ordinary Shares	100,000	⁽²⁾	100,000	I	Held by trustee⁽⁴⁾
Employee Stock Option (right to buy)	$5.87⁽¹⁾⁽²⁾	04/07/2026		A		100,000		12/22/2026⁽³⁾	06/22/2029	Ordinary Shares	100,000	⁽²⁾	100,000	I	Held by trustee⁽⁴⁾
Employee Stock Option (right to buy)	$6.12⁽¹⁾	04/07/2026		D			100,000	12/22/2026⁽³⁾	06/22/2029	Ordinary Shares	100,000	⁽²⁾	100,000	I	Held by trustee⁽⁴⁾
Employee Stock Option (right to buy)	$7.25⁽¹⁾⁽²⁾	04/07/2026		A		100,000		12/10/2027⁽³⁾	12/10/2035	Ordinary Shares	100,000	⁽²⁾	100,000	I	Held by trustee⁽⁴⁾
Employee Stock Option (right to buy)	$7.5⁽¹⁾	04/07/2026		D			100,000	12/10/2027⁽³⁾	12/10/2035	Ordinary Shares	100,000	⁽²⁾	100,000	I	Held by trustee⁽⁴⁾
Employee Stock Option (right to buy)	$7.25⁽¹⁾⁽²⁾	04/07/2026		A		100,000		12/10/2028⁽³⁾	12/10/2035	Ordinary Shares	100,000	⁽²⁾	100,000	I	Held by trustee⁽⁴⁾
Employee Stock Option (right to buy)	$7.5⁽¹⁾	04/07/2026		D			100,000	12/10/2028⁽³⁾	12/10/2035	Ordinary Shares	100,000	⁽²⁾	100,000	I	Held by trustee⁽⁴⁾
Employee Stock Option (right to buy)	$7.25⁽¹⁾⁽²⁾	04/07/2026		A		100,000		12/10/2029⁽³⁾	12/10/2035	Ordinary Shares	100,000	⁽²⁾	100,000	I	Held by trustee⁽⁴⁾
Employee Stock Option (right to buy)	$7.5⁽¹⁾	04/07/2026		D			100,000	12/10/2029⁽³⁾	12/10/2035	Ordinary Shares	100,000	⁽²⁾	100,000	I	Held by trustee⁽⁴⁾

Explanation of Responses:

1. All exercise prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of April 6, 2026.

2. The exercise price of the options was adjusted pursuant to the provisions of the Company's 2011 Share Award Plan in connection with a cash dividend distribution declared by the Company's board of directors on March 11, 2026. There are no other changes to the terms and conditions of the option award.

3. Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant.

4. Held by trustee under the Company's 2011 Share Award Plan.

	/s/ Amir London	04/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

Kamada CEO reports option grant adjustments

Rhea-AI Filing Summary

Positive

Negative